英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
reven查看　reven　在百度字典中的解释百度英翻中〔查看〕
reven查看　reven　在Google字典中的解释Google英翻中〔查看〕
reven查看　reven　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Reven Pharmaceuticals - A New Generation of Pharmacological Solutions
    Reven Pharmaceuticals: diligently pursuing scientific innovation to exponentially improve health and well-being
  • Reven Pharmaceuticals Response - Reven hits back, opposing SEC’s . . .
    This filing represents Reven’s first step towards disputing the SEC’s one-sided narrative and setting the record straight Referenced in article: Peter Lange, Michael Volk, Brian Denomme, James Ervin, Leah Schaatt, Lee-Ann Frost
  • News - Reven Pharmaceuticals
    Recent Reven Pharma press releases and other news in the pharma industry, including broad medical treatment news and current issues
  • Reven Asks Court to Consider Additional Ongoing . . . - Reven Pharmaceuticals
    Moreover, Reven is now facing a lawsuit from Fox Rothschild LLP, Reven’s former intellectual property and patent counsel, based on legal fees Reven has been unable to pay The case is Case Number 2023-cv-31418 in the District Court of Jefferson County, Colorado
  • Overview - Reven Pharmaceuticals
    At Reven Pharma, we believe in promoting cellular wellness through cellular restoration RJX is a fixed combination intravenous (IV) drug therapy technology platform designed to contribute multiple modes of action having the capacity to address a variety of unmet medical needs
  • Reven Pharmaceuticals Wins FDA Approval of its IND Application for . . .
    Golden, Colorado (BUSINESS WIRE)– Reven Holdings, Inc (“Reven”) is a privately held clinical stage biotechnology and pharmaceutical company dedicated to the discovery and development of novel treatment platforms for cancer, viral illnesses—including COVID-19—and inflammatory disorders Reven today announced that the U S Food and Drug Administration (FDA) has approved the
  • Modalities - Reven Pharmaceuticals
    Reven’s scientific research team has an ongoing commitment to compile and review RJX patient and study data to grow in our understanding of RJX As an important part of this process, the team has spent countless hours scouring scientific literature to understand the pathology that RJX is positioned to influence To organize this effort, Reven researchers have categorized candidate modalities
  • Products - Reven Pharmaceuticals
    RJX targets Critical Limb Ischemia patients facing amputation as well as a larger patient population suffering PAD and other vascular related medical conditions
  • Reven Announces the Appointment of Eminent Physician-Scientist Fatih M . . .
    Golden, Colorado, Thursday June 26, 2020, 1:00am MDT (BUSINESS WIRE)—Reven Holdings, Inc (“Reven”), a privately held clinical stage biotechnology and pharmaceutical company dedicated to the discovery and development of novel treatment platforms for cancer, viral illnesses—including COVID-19—and inflammatory disorders, today announced the appointment of Dr Fatih M Uckun as its
  • REVEN ANNOUNCES A STRATEGIC LICENSING PARTNERSHIP WITH ENLIGHTENED . . .
    REVEN ANNOUNCES A STRATEGIC LICENSING PARTNERSHIP WITH ENLIGHTENED NUTRACEUTICAL SOLUTIONS, LLC (ENS) TO ALLOW ENS TO LEVERAGE REVEN’S CLINICAL RESEARCH IN ANTI-INFLAMMATORY AND ANTIOXIDANT MEDICINE TOWARD ITS EFFORTS TO DEVELOP NEW PROPRIETORY VITAMIN AND NUTRIENT BASED PRODUCTS





中文字典-英文字典  2005-2009